Name: UMIN ID:
Unique ID issued by UMIN | UMIN000024688 |
---|---|
Receipt number | R000028403 |
Scientific Title | The feasibility study of TAS-118 plus Oxaliplatin or TAS-118 monotherapy as perioperative chemotherapy for locally advanced gastric cancer |
Date of disclosure of the study information | 2016/11/09 |
Last modified on | 2020/11/06 10:35:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/11/02 18:36:26 | ||
2 | Update | 2016/11/09 12:02:31 | Date of disclosure of the study information |
|
3 | Update | 2016/12/05 15:11:15 | Interventions/Control_1 Interventions/Control_1 |
|
4 | Update | 2016/12/05 15:46:13 | Name of secondary funder(s) Name of secondary funder(s) Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 IND to MHLW Institutions |
|
5 | Update | 2016/12/05 15:47:29 | Recruitment status Anticipated trial start date |
|
6 | Update | 2019/02/20 11:05:28 | Recruitment status |
|
7 | Update | 2019/11/06 11:15:05 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Division name Division name Address Address TEL Email1 Organization Organization Address Address Tel |
|
8 | Update | 2019/11/06 11:17:46 | Division name |
|
9 | Update | 2019/11/07 18:09:37 | Email |
|
10 | Update | 2019/11/07 18:32:10 | Tel1 |
|
11 | Update | 2019/11/20 11:03:32 | Organization Organization Email1 |
|
12 | Update | 2020/01/10 11:11:50 | Last name of lead principal investigator |
|
13 | Update | 2020/01/10 11:14:18 | Key inclusion criteria |
|
14 | Update | 2020/11/06 10:35:27 | Recruitment status Date of IRB Last follow-up date Date trial data considered complete |